Bayer acquired Perfuse Therapeutics and its experimental endothelin-blocking eye implant PER-001, and partnered with AI firm ...
ISTANBUL, Türkiye, February 19, 2026 (EZ Newswire) -- In response to the rapidly expanding global market for hair restoration services and the critical need for clinical standardization, Dr. Yetkin ...
ASHBURN, Va.--(BUSINESS WIRE)--I2Pure is excited to announce that our Chief Scientist, Dr. Ilker Bayer, has been named a ‘Highly Ranked Scholar’ by ScholarGPS - one who ranks in .05% of 30 million ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results